Trial design and radiographic outcomes in PsA IL-23 trials
A November 2026 JAAD article by David Oberlin and Jesse Veenstra examines how trial design shapes interpretation of radiographic outcomes across IL-23 inhibitor trials in psoriatic arthritis.